临床儿科杂志
臨床兒科雜誌
림상인과잡지
2014年
6期
528-531
,共4页
朱丽丽%张海邻%温顺航%张艳%李昌崇
硃麗麗%張海鄰%溫順航%張豔%李昌崇
주려려%장해린%온순항%장염%리창숭
肺炎支原体肺炎%临床路径%变异%儿童
肺炎支原體肺炎%臨床路徑%變異%兒童
폐염지원체폐염%림상로경%변이%인동
Mycoplasma pneumoniae pneumonia%clinical pathway%variations%child
目的:评估肺炎支原体肺炎(MPP)临床路径的实施效果。方法采用回顾性研究方法,分析并比较采用临床路径治疗的145例和非临床路径治疗的45例MPP患儿在住院时间、住院费用、治愈率等方面的差异,并探讨临床路径的变异情况。结果临床路径组的住院时间为9 d(6~10 d),短于非临床路径组的10 d(7~12.5 d),差异有统计学意义(P=0.003);治愈率93.8%,高于非临床路径组的84.4%,差异有统计学意义(P=0.043);住院费用为4696.5元(3608.3~5677.6元),高于非临床路径组的3175.3元(2490.8~4585.0元),差异有统计学意义(P<0.001)。临床路径变异率48.3%(70/145)。结论实施MPP临床路径可提高治愈率,缩短住院时间,但该路径在临床实施过程中变异率较高,仍需加以完善并推广使用。
目的:評估肺炎支原體肺炎(MPP)臨床路徑的實施效果。方法採用迴顧性研究方法,分析併比較採用臨床路徑治療的145例和非臨床路徑治療的45例MPP患兒在住院時間、住院費用、治愈率等方麵的差異,併探討臨床路徑的變異情況。結果臨床路徑組的住院時間為9 d(6~10 d),短于非臨床路徑組的10 d(7~12.5 d),差異有統計學意義(P=0.003);治愈率93.8%,高于非臨床路徑組的84.4%,差異有統計學意義(P=0.043);住院費用為4696.5元(3608.3~5677.6元),高于非臨床路徑組的3175.3元(2490.8~4585.0元),差異有統計學意義(P<0.001)。臨床路徑變異率48.3%(70/145)。結論實施MPP臨床路徑可提高治愈率,縮短住院時間,但該路徑在臨床實施過程中變異率較高,仍需加以完善併推廣使用。
목적:평고폐염지원체폐염(MPP)림상로경적실시효과。방법채용회고성연구방법,분석병비교채용림상로경치료적145례화비림상로경치료적45례MPP환인재주원시간、주원비용、치유솔등방면적차이,병탐토림상로경적변이정황。결과림상로경조적주원시간위9 d(6~10 d),단우비림상로경조적10 d(7~12.5 d),차이유통계학의의(P=0.003);치유솔93.8%,고우비림상로경조적84.4%,차이유통계학의의(P=0.043);주원비용위4696.5원(3608.3~5677.6원),고우비림상로경조적3175.3원(2490.8~4585.0원),차이유통계학의의(P<0.001)。림상로경변이솔48.3%(70/145)。결론실시MPP림상로경가제고치유솔,축단주원시간,단해로경재림상실시과정중변이솔교고,잉수가이완선병추엄사용。
Objective To investigate the efficacy of the clinical pathway introduced in children with Mycoplasma pneu-moniae pneumonia (MMP). Methods Based on a retrospective study, the length of hospital stay, hospital expenses and curative rate were compared between 145 MMP patients managed according to clinical pathway and other 45 MMP patients. The causes of variation were analyzed in the clinical pathway group as well. Results The length of hospital stay in clinical pathway group [9 (6~10) days] was significantly shorter than that in the control group [10 (7-12.5) days] (P=0.003). The curative rate (93.8%) was significantly higher than that in the control group (84.4%) (P=0.043). The hospital expenses [4 696.5 (3 608.3-5 677.6) CNY] was significantly higher than that in the control group [3175.3 (2490.8-4585.0) CNY] (P<0.001). The variation rate of clinical pathway was 48.3%(70/145 cases) in clinical pathway group. Conclusions The curative rate is improved and the length of hospital stay is shortened after the clinical pathway is introduced in MMP children. However, there is a high variation rate in the clinical pathway. It is necessary to optimize the clinical pathway before it is adapted in clinic.